When we saw the enhanced bioavailability conferred on curcumin by piperine, AOR was initially excited, as bioavailability of curcumin in humans is very low (and proportionately much lower than in rodents, in whom very promising research has been performed). Once we began digging into the research on this substance, however, we concluded that it would be irresponsible to systematically increase exposure to this phytochemical.
It's worth gaining some understanding of exactly why piperine enhances the bioavailability of some substances (and only some: there seems to be a widespread belief in the industry that piperine enhances absorption of all nutrients, such that you see piperine mixed in with almost any supplement you care to mention -- even basic multivitamins). While there are several mechanisms at work, the primary one is the inhibition of detoxification enzymes, including a highly nospecific effect on the Phase I (cytochrome P450) enzymes, and an impairment of glucuronidation (a Phase II conjugation process). Piperine is "a potent inhibitor of UDP-GDH [UDP-glucose dehydrogenase (UDP-GDH)]” and of "glucuronidation potentials of rat and guinea pig liver and intestine" [1]. It is "a nonspecific inhibitor of drug metabolism which shows little discrimination between different cytochrome P-450 forms. Oral administration of piperine in rats strongly inhibited the hepatic AHH [arylhydrocarbon hydroxylase] and UDP-glucuronyltransferase activities." [2] "Piperine caused a concentration-related decrease in UDP-glucuronic acid content and the rate of glucuronidation in the [intestinal] cells. ... Rate of glucuronidation ... was dependent on the endogeneous level of UDP-glucuronic acid. At 50 microM piperine, the rate of glucuronidation was reduced to about 50% of the basal rate. Piperine caused noncompetitive inhibition of hepatic microsomal UDP-glucuronyltransferase with Ki of 70 microM." [3]
Substances whose bioavailability is inhibited by being biotransformed by these enzymes will therefore have their bioavailability enhanced by piperine. This is the basis, in particular, for its enhancement of curcumin bioavailability. The problem with this is that these enzymes also protect us from a variety of toxic substances -- which is, after all, why we have them in the first place.
Thus, "piperine was found to promote DNA damage and cytotoxicity induced by benzo[a]pyrene (B[a]P [a carcinogenic compound formed as a result of incomplete combustion of organic materials, found in engine exhaust, coal-, oil-, and wood-burning stove emissions, poorly-tuned furnaces, cigarette smoke, industrial soot, charred foods, incinerators, coke ovens, and asphalt processing, and secondarily in contaminated drinking water] in cultured V-79 lung fibroblast cells ... due to mechanisms that decrease the activities of [the detoxification enzymes] GST [glutathione S-transferase] and UDP-GTase [uridine diphosphate glucuronyl transferase] and increase the formation of a B[a]P-DNA adduct.” [4] Likewise [3] finds that piperine inhibits the "Rate of glucuronidation of 3-hydroxybenzo (a) pyrene ... dependent on the endogeneous level of UDP-glucuronic acid. "
It also "enhances the bioavailability of aflatoxin B1 in rat tissues," although the net effect of this is unclear [5]; aflatoxin is a mycotoxin that often contaminates corn and peanuts that are not kept dry and refrigerated, and is still a major cause of hepatocelluar carcinoma in China and much of the developing world. While under control in OECD countries, it is certainly not absent from the food supply, and enhancing its bioavialability is prima facie a bad idea.
Independently of impaired detoxification, "Piperine ... also reacted with nitrite and produced compounds showing mutagenicity in bacteria without metabolic activation." [6]
It should be noted that in other models, piperine appears to be protective against aspects of the cancer process, but the state of research is not clear enough to allow anyone to perform a reliable risk-to-benefit analysis of piperine. Healthy life extensionists, in our judgement, should avoid it.
To your health!
AOR
1. Reen RK, Jamwal DS, Taneja SC, Koul JL, Dubey RK, Wiebel FJ, Singh J. Impairment of UDP-glucose dehydrogenase and glucuronidation activities in liver and small intestine of rat and guinea pig in vitro by piperine. Biochem Pharmacol. 1993 Jul 20;46(2):229-38.
2. Atal CK, Dubey RK, Singh J. Biochemical basis of enhanced drug bioavailability by piperine: evidence that piperine is a potent inhibitor of drug metabolism. J Pharmacol Exp Ther. 1985 Jan;232(1):258-62.
3. Singh J, Dubey RK, Atal CK. Piperine-mediated inhibition of glucuronidation activity in isolated epithelial cells of the guinea-pig small intestine: evidence that piperine lowers the endogeneous UDP-glucuronic acid content. J Pharmacol Exp Ther. 1986 Feb;236(2):488-93.
4. Chu CY, Chang JP, Wang CJ. Modulatory effect of piperine on benzo[a]pyrene cytotoxicity and DNA adduct formation in V-79 lung fibroblast cells. Food Chem Toxicol. 1994 Apr;32(4):373-7.
5. Allameh A, Saxena M, Biswas G, Raj HG, Singh J, Srivastava N. Piperine, a plant alkaloid of the piper species, enhances the bioavailability of aflatoxin B1 in rat tissues. Cancer Lett. 1992 Jan 31;61(3):195-9.
6. Wakabayashi K, Nagao M, Sugimura T. Mutagens and carcinogens produced by the reaction of environmental aromatic compounds with nitrite. Cancer Surv. 1989;8(2):385-99.
That it enhances bioavailability of some (again, not all) substances is not disputed. The point, again, is that glucuronidation is a central detoxification process. Unless you have a totally toxin-free diet -- no overcooked foods, no pesticide residues in your meats and vegetables, no trace quantities of mycotoxins in your bread, etc -- and unless you have no sex steroids in your system, you rely on these processes to protect you against cancer on a continuous basis. Inhibiting them for a few hours every day to get better bioavailability out of your supplements is rather to mix up one's priorities.
To your health!
AOR
Thanks for digging it out Funk.

Help






















RSS Feed